Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial-Reference-Cited by-同舟云学术

Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial

Published:2020-07-01 Issue:7 Volume:5 Page:757
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Fiuzat Mona¹,Ezekowitz Justin²³,Alemayehu Wendimagegn³,Westerhout Cynthia M.³,Sbolli Marco⁴⁵,Cani Dario⁴⁵,Whellan David J.⁶,Ahmad Tariq⁷,Adams Kirkwood⁸,Piña Ileana L.⁹,Patel Chetan B.¹,Anstrom Kevin J.¹,Cooper Lawton S.¹⁰,Mark Daniel¹,Leifer Eric S.¹⁰,Felker G. Michael¹,Januzzi James L.¹¹,O’Connor Christopher M.¹⁵

Affiliation:

1. University Medical Center and Duke Clinical Research Institute, Duke University, Durham, North Carolina

2. Heart Function Clinic, Division of Cardiology, University of Alberta, Edmonton, Alberta, Canada

3. Canadian VIGOUR Centre, Katz Group Centre for Pharmacy and Health Research, University of Alberta, Edmonton, Alberta, Canada

4. Department of Cardiology, University of Brescia, Brescia, Italy

5. Inova Heart and Vascular Institute, Fairfax, Virginia

6. Division of Cardiology, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania

7. Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut

8. Department of Cardiology, University of North Carolina School of Medicine, Chapel Hill

9. Division of Cardiology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York

10. Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, Maryland

11. Baim Institute for Clinical Research, Cardiology Division, Massachusetts General Hospital, Boston

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Link

https://jamanetwork.com/journals/jamacardiology/articlepdf/2764433/jamacardiology_fiuzat_2020_oi_200016.pdf

Reference13 articles.

1. Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF Registry.;Greene;J Am Coll Cardiol,2018

2. Association of changes in heart failure treatment with patients’ health status: real-world evidence from CHAMP-HF.;Thomas;JACC Heart Fail,2019

3. Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction.;Januzzi;J Am Coll Cardiol,2011

4. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.;Felker;Am Heart J,2009

5. N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial.;Lainchbury;J Am Coll Cardiol,2009

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving Utilization of Guideline-Directed Medical Therapy for Heart Failure;The Journal for Nurse Practitioners;2024-09

2. Titration of Medications After Acute Heart Failure Is Safe, Tolerated, and Effective Regardless of Risk;JACC: Heart Failure;2024-09

3. Differences in the approach to guideline‐directed medical therapy in patients with heart failure with reduced ejection fraction: A survey of cardiologists, internists, and pharmacists;JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY;2024-07-23

4. High-intensity care for GDMT titration;Heart Failure Reviews;2024-07-22

5. A Quality Improvement-based Approach to Implementing a Remote Monitoring–Based Bundle in Transitional Care Patients for Heart Failure;The Joint Commission Journal on Quality and Patient Safety;2024-07